Are Stem Cell Injections Covered by Medicare
Stem cell injections are a popular treatment for various conditions, but are they covered by Medicare? The answer is maybe. Medicare will cover stem cell injections if they are considered medically necessary and if the patient receiving the treatment meets certain criteria. However, here is some important information from Dr. Centeno that you should be […]
Kadimastem Receives Approval of Patent Registration for Its Cell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes in a Third Territory
NESS ZIONA, Israel, Sept. 28, 2022 /PRNewswire/ — Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing treatments for ALS and diabetes, has been granted its third patent approval for the company’s innovative cell selection and enrichment technology and its use in the production of IsletRx, the company’s treatment and potential cure for diabetes. […]
BioRestorative Therapies to Participate in the Roth Inaugural Healthcare Opportunities Conference
MELVILLE, NY., Sept. 27, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that CEO Lance Alstodt will be participating in the Roth Inaugural Healthcare Opportunities Conference being held at The Yale Club in New York City on October 6, 2022. […]
CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world’s premier diabetic foot conference (DFCon) in Los Angeles
LOS ANGELES, Sept. 26, 2022 /PRNewswire/ — CRC is delighted to announce attendance at DFCon, the global specialist multidisciplinary congress focused on the diabetic foot held in late September 2022 in Los Angeles, USA. The meeting is a gathering of a wide range of both generalists and specialists who diagnose and manage diabetic feet, to […]
Jasper Therapeutics to Present at Upcoming Conferences
REDWOOD CITY, Calif., Sept. 23, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the Company will be participating in the following conferences in September. Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference (New York City) Ronald Martell, CEO, will participate in […]
Talaris Therapeutics to Present at William Blair’s Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event
BOSTON and LOUISVILLE, Ky., Sept. 21, 2022 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive Officer of Talaris, will present at […]
Is stem cell therapy covered by insurance?
Stem cell therapy is a new and promising treatment for a variety of diseases and injuries, but it can also be very expensive. Insurance companies are starting to cover stem cell therapy, but there are still many restrictions. As this industry continues to grow, we hope to see more major insurance carriers start to cover […]
StemExpress Opens New Collection Center in Biotech Hub of Boston, MA
CAMBRIDGE, Mass., Sept. 15, 2022 /PRNewswire/ — StemExpress is excited to announce the opening of their newest StemExpress cell collection center in Boston, Massachusetts. StemExpress is relocating from Arlington, MA to the prestigious research hub of Cambridge, MA. The move promises more partnerships and better logistics for client needs, opening doors for more scalable cell […]
Life-Saving Innovations in Cancer-Fighting Stem Cell Transplants and Pioneering Research in HIV, Autism and Cerebral Palsy to be Featured at World Cord Blood Day 2022
TUCSON, Ariz., Sept. 14, 2022 /PRNewswire/ — We are pleased to announce World Cord Blood Day 2022 (WCBD 2022) will take place on November 15th, featuring a free online medical conference and educational events worldwide. This year’s official online conference will highlight innovations in cancer-fighting stem cell transplants using cord blood, as well as ground-breaking […]
Lyell Immunopharma Presents First in Human Trial Design of LYL797 at ESMO 2022
SOUTH SAN FRANCISCO, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company dedicated to developing curative cell therapies for patients with solid tumors, announced today that a poster describing the first-in-human Phase 1 trial design for LYL797, Lyell’s ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic […]